Active substance (DCI)
- axicabtagene ciloleucel
history (9)
-
7/20/23
YESCARTA (axicabtagene ciloleucel) - Lymphome diffus à grandes cellules B
-
4/6/23
YESCARTA (axicabtagene ciloleucel) - Lymphome folliculaire
-
2/15/23
YESCARTA (axicabtagène ciloleucel) - Lymphome diffus à grandes cellules B (LDGCB) et lymphome de haut grade à cellules B (LHGCB)
CAV : -
2/16/23
YESCARTA (axicabtagene ciloleucel) - Lymphome LDGCB - LHGCB
-
7/13/22
YESCARTA (axicabtagene ciloleucel) - Lymphome diffus à grandes cellules B
-
1/18/23
YESCARTA (axicabtagène ciloleucel) - Lymphome folliculaire
CAV :
-
4/14/22
YESCARTA (axicabtagene ciloleucel) - Lymphome folliculaire
-
3/24/21
YESCARTA (axicabtagene ciloleucel)
CAV : -
12/5/18
YESCARTA (axicabtagene ciloleucel), CAR T anti-CD19
CAV :